MR Fingerprinting of Adult Brain Tumors: Initial Experience
暂无分享,去创建一个
M Griswold | M. Schluchter | M. Griswold | V. Gulani | A. Sloan | J. Sunshine | D. Ma | S. Pahwa | Yun Jiang | S. Margevicius | C. Badve | A. Yu | M. Rogers | V Gulani | S. Dastmalchian | Y. Jiang | Z. Lu | J. Sunshine | M Schluchter | A Sloan | C Badve | A Yu | S Dastmalchian | M Rogers | D Ma | Y Jiang | S Margevicius | S Pahwa | Z Lu | J Sunshine | Chaitra Badve | Matthew Rogers | Andrew E. Sloan | Shivani Pahwa | Andrew Sloan
[1] M Komiyama,et al. MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. , 1987, AJNR. American journal of neuroradiology.
[2] Z. Song,et al. Differentiation between low-grade and high-grade glioma using combined diffusion tensor imaging metrics , 2013, Clinical Neurology and Neurosurgery.
[3] C. Thomsen,et al. Tissue Characterization of Intracranial Tumors by MR Imaging , 1991, Acta radiologica.
[4] Z. Wu,et al. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. , 2004, Clinical radiology.
[5] M. Schluchter,et al. Simultaneous T1 and T2 Brain Relaxometry in Asymptomatic Volunteers Using Magnetic Resonance Fingerprinting , 2015, Tomography.
[6] D. Cicchetti. Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. , 1994 .
[7] Ming Zhang,et al. Differentiation of pure vasogenic edema and tumor-infiltrated edema in patients with peritumoral edema by analyzing the relationship of axial and radial diffusivities on 3.0T MRI , 2013, Clinical Neurology and Neurosurgery.
[8] B A Kall,et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.
[9] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[10] M. Griswold,et al. Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom , 2017, Magnetic resonance in medicine.
[11] Stephen J Sawiak,et al. MR fingerprinting with simultaneous B1 estimation , 2015, Magnetic resonance in medicine.
[12] G. Barger,et al. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates , 2013, Journal of Neuro-Oncology.
[13] J. Hennig,et al. Pseudo Steady‐State Free Precession for MR‐Fingerprinting , 2017, Magnetic resonance in medicine.
[14] Albert Lai,et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab , 2011, Journal of Neuro-Oncology.
[15] Lawrence L. Wald,et al. Maximum likelihood reconstruction for magnetic resonance fingerprinting , 2016, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).
[16] J. Duerk,et al. Magnetic Resonance Fingerprinting , 2013, Nature.
[17] V. Haughton,et al. T1, T2 and proton density measurements in the grading of cerebral gliomas , 2004, European Radiology.
[18] Sean C L Deoni,et al. Quantitative Relaxometry of the Brain , 2010, Topics in magnetic resonance imaging : TMRI.
[19] Thomas Czech,et al. Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[20] C. Zimmer,et al. Multimodal imaging in cerebral gliomas and its neuropathological correlation. , 2014, European journal of radiology.
[21] M. Griswold,et al. MR fingerprinting using fast imaging with steady state precession (FISP) with spiral readout , 2015, Magnetic resonance in medicine.
[22] Yong Chen,et al. MR Fingerprinting for Rapid Quantitative Abdominal Imaging. , 2016, Radiology.
[23] K. Swanson,et al. Correlation of in vitro infiltration with glioma histological type in organotypic brain slices , 2004, British Journal of Cancer.
[24] R. Deichmann,et al. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI , 2014, Neuroradiology.
[25] R. Lober,et al. The incidence and significance of multiple lesions in glioblastoma , 2013, Journal of Neuro-Oncology.
[26] R. Damadian. Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.
[27] R. DePinho,et al. Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.
[28] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[29] J. Henson,et al. Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.
[30] Siegfried Trattnig,et al. Magnetic Resonance Fingerprinting - a promising new approach to obtain standardized imaging biomarkers from MRI , 2015, Insights into Imaging.
[31] P. Kehrli,et al. [Epidemiology of brain metastases]. , 1999, Neuro-Chirurgie.
[32] Jill S. Barnholtz-Sloan,et al. Epidemiologic and Molecular Prognostic Review of Glioblastoma , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[33] T. Cloughesy,et al. Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI , 2015, Clinical Cancer Research.
[34] M. Berger,et al. Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2007, American Journal of Neuroradiology.
[35] R. Tanaka,et al. Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.
[36] Alina Jurcoane,et al. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. , 2013, Neuro-oncology.
[37] T. Carpenter,et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. , 2006, AJNR. American journal of neuroradiology.
[38] Susan Chang,et al. Pseudoprogression and pseudoresponse: Challenges in brain tumor imaging , 2009, Current neurology and neuroscience reports.
[39] J. Ironside,et al. Diagnosis and pathogenesis of gliomas , 2007 .
[40] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Mark Muzi,et al. Positron emission tomography imaging of brain tumors. , 2003, Neuroimaging clinics of North America.
[42] J. Vymazal,et al. Quantitative MR imaging and spectroscopy of brain tumours: a step forward? , 2012, European Radiology.
[43] T. Goto,et al. Diffusion tensor-based tumor infiltration index cannot discriminate vasogenic edema from tumor-infiltrated edema , 2010, Journal of Neuro-Oncology.
[44] Lutz Tellmann,et al. Comparison of (18)F-FET and (18)F-FDG PET in brain tumors. , 2009, Nuclear medicine and biology.
[45] Jesse I. Hamilton,et al. MR fingerprinting for rapid quantification of myocardial T1, T2, and proton spin density , 2017, Magnetic resonance in medicine.
[46] Yi Yan,et al. Quantitative analysis of glioma cell invasion by diffusion tensor imaging , 2010, Journal of Clinical Neuroscience.
[47] T. Araki,et al. Magnetic resonance imaging of brain tumors: measurement of T1. Work in progress. , 1984, Radiology.
[48] M. Thelen,et al. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.
[49] S. Filice,et al. Lipid and Macromolecules Quantitation in Differentiating Glioblastoma From Solitary Metastasis: A Short–Echo Time Single-Voxel Magnetic Resonance Spectroscopy Study at 3 T , 2013, Journal of computer assisted tomography.
[50] P. Desmond,et al. Diffusion Tensor Imaging in Glioblastoma Multiforme and Brain Metastases: The Role of p, q, L, and Fractional Anisotropy , 2008, American Journal of Neuroradiology.
[51] P. Brown,et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.
[52] A. Chetrit,et al. Original articles. , 2002, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[53] F. Howe,et al. Differentiation of metastases from high‐grade gliomas using short echo time 1H spectroscopy , 2004, Journal of magnetic resonance imaging : JMRI.
[54] N. Bulakbaşı,et al. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. , 2003, AJNR. American journal of neuroradiology.